Hepatic arterial infusion therapy

The U.S. Food and Drug Administration ( FDA ) has approved Cyramza ( Ramucirumab injection, 10 mg/mL solution ), as...


The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) issued...


Kyprolis ( Carfilzomib ) for Injection, a proteasome inhibitor, is approved for the treatment of patients with multiple myeloma who...


A study showed that patients whose colorectal cancer has spread to the liver who received an approach called hepatic arterial...


Preliminary results of a phase I study showed that a single injection of a genetically engineered virus has shown...